3 Stocks Priced Below $50 That Raise Our Doubts

Exploring Stocks in the $10–$50 Range

Stocks priced between $10 and $50 often represent established mid-cap companies with a history of performance and significant potential for future growth. While these stocks generally present less risk than penny stocks, they can still be subject to market fluctuations, as many have yet to achieve the scale of larger corporations.

This is where StockStory steps in—we conduct in-depth analysis to uncover businesses with strong financial health, helping you make informed investment decisions. Below, we highlight three stocks under $50 that may not be the best choices right now, along with some alternative options worth considering.

Pegasystems (PEGA)

Current Price: $44.80

Pegasystems (NASDAQ:PEGA) specializes in software solutions that streamline business operations and enhance customer engagement through automation and artificial intelligence, utilizing a “Center-out Business Architecture” to break down organizational barriers.

Why PEGA May Not Be the Best Bet

• Over the past five years, revenue has grown by 11.4% annually—a modest rate for a software company in a rapidly expanding sector.
• Intense competition forces the company to increase spending on sales and marketing, often with limited returns.
• On the positive side, operating margins improved by 6.8 percentage points last year, indicating some operational efficiency gains.

Currently trading at $44.80 per share (4x forward price-to-sales), Pegasystems may warrant a closer look before adding it to your portfolio.

Sally Beauty (SBH)

Current Price: $16.44

Sally Beauty (NYSE:SBH) serves both individual consumers and salon professionals, offering a wide selection of salon-grade beauty and haircare products.

Reasons to Consider Selling SBH

• The company’s focus on optimizing existing stores rather than expanding suggests limited growth ambitions.
• Same-store sales have been underwhelming for the past two years, indicating that customers are not fully embracing its offerings or in-store experience.
• With annual revenue of $3.71 billion, Sally Beauty faces challenges competing with larger industry players who benefit from greater economies of scale.

At $16.44 per share, Sally Beauty trades at 7.5x forward P/E.

10x Genomics (TXG)

Current Price: $21.65

Founded in 2012, 10x Genomics (NASDAQ:TXG) empowers researchers with tools and software to analyze biological systems at the single-cell level, pushing the boundaries of traditional life sciences research.

Why We’re Cautious About TXG

• Sales growth has been sluggish, with just 1.9% annual growth over the past two years—well below the healthcare sector average.
• With revenue at $642.8 million, the company has yet to reach the scale of industry leaders.
• Negative returns on capital suggest that recent expansion efforts have not been profitable.

Trading at $21.65 per share (4.1x forward price-to-sales), 10x Genomics may not be the best fit for every investor.

Stocks with Greater Potential

Building a successful portfolio means looking ahead, not relying on yesterday’s winners. As certain popular stocks become increasingly crowded, the risk of holding them rises.

The next generation of high-growth companies can be found in our Top 5 Strong Momentum Stocks for this week. This handpicked group of High Quality stocks has delivered an impressive 244% return over the past five years (as of June 30, 2025).

Our 2020 selections included now-household names like Nvidia, which soared 1,326% between June 2020 and June 2025, as well as lesser-known companies such as Comfort Systems, which achieved a 782% five-year return. Start your search for the next breakout stock with StockStory today.